Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 47

Sort by

Sort Order Select

Journal Articles

Computational Analysis Model Applied to Spanish Gaucher Registry Data

Marcio M Andrade-Campos, MD PhD, Laura Lopez de Frutos, PhD, Jorge J Cebolla, MSc, Blanca Medrano-Engay, PhD, Mercedes Roca-Espiau, PhD, Beatriz Gomez-Barrera, David Iniguez, Pilar Giraldo, PhD

Blood (2019) 134 (Supplement_1): 2323.

https://doi.org/10.1182/blood-2019-122347

Published: 2019

Journal Articles

Myeloma Cells Have the Ability to Suppress Th1-Inducing Capacity but Enhance Th2-Mediated Response of Dendritic Cells By Producing Factors Other Than Soluble SLAMF7

Yoshiko Azuma, MD, Tomoki Ito, MD PhD, Muneo Inaba, PhD, Kai Imai, MD, Hideaki Yoshimura, MD, Masaaki Hotta, MD, Takahisa Nakanishi, MD PhD, Shinya Fujita, MD PhD, Aya Nakaya, MD PhD, Atsushi Satake, MD PhD, Kazuyoshi Ishii, MDMPH,PhD, Shosaku Nomura, MD PhD

Blood (2018) 132 (Supplement 1): 1938.

https://doi.org/10.1182/blood-2018-99-113282

Published: 2018

Journal Articles

Immune Dysfunction in Patients with MDS Is Partially Corrected in EPO-Treated Patients: Differences According to WHO Classification

Howard S Oster, MD PhD, Naamit Deshet-Unger, MSc, Drorit Neumann, PhD, Moshe Mittelman, MD, Nir Maaravi, MD, Sara Prutchi-Sagiv, PhD, Golishevski Nataliya, MD

Blood (2016) 128 (22): 3165.

https://doi.org/10.1182/blood.V128.22.3165.3165

Published: 2016

Journal Articles

A Phase 2 Study of Lenalidomide to Repair Immune Synapse Response and Humoral Immunity in Early-Stage, Asymptomatic Chronic Llmphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) with High-Risk Genomic Features

Jeffrey A. Jones, MD MPH, Amy J. Johnson, PhD, Farrukh T. Awan, Quihong Zhao, MAS, Natarajan Muthusamy, DVM, PhD, Kami J. Maddocks, MD, Leslie A. Andritsos, MD, Kerry A. Rogers, MD, Jennifer A. Woyach, MD, Gerard Lozanski, MD, Nyla A. Heerema, PhD, Cathy Brookfield, BSN, Amy S Ruppert, MAS, John C. Byrd, MD

Blood (2016) 128 (22): 4388.

https://doi.org/10.1182/blood.V128.22.4388.4388

Published: 2016

Journal Articles

Sun C, Tian X, Lee YS, et al. Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib. Blood. 2015;126(19): 2213-2219 .

Blood (2016) 128 (7): 1020.

https://doi.org/10.1182/blood-2016-06-725010

Published: 2016

Journal Articles

To B or not to B maintained?

Anna-Karin E. Palm, Patrick C. Wilson

Blood (2016) 128 (3): 317–318.

https://doi.org/10.1182/blood-2016-06-717538

Published: 2016

Journal Articles

Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy

Blood (2016) 128 (3): 360–370.

https://doi.org/10.1182/blood-2016-01-694356

Published: 2016

Includes: Supplemental data

Journal Articles

The Role of Signal-Transducing Adaptor Protein-2 in Early T Lymphopoiesis in Thymus

Michiko Ichii, Natsuko Fujita, Daisuke Okuzaki, Tetsuo Maeda, Yuichi Sekine, Shigeyuki Kon, Ryuta Muromoto, Kenji Oritani, Tadashi Matsuda, Yuzuru Kanakura

Blood (2014) 124 (21): 752.

https://doi.org/10.1182/blood.V124.21.752.752

Published: 2014

Journal Articles

Decreasing the Humoral Response to Factor VIII By Targeted Deletion of Factor VIII - Specific B Cells

Rebecca C. Markovitz, John F. Healey, W. Hunter Baldwin, Ernest T. Parker, Shannon L. Meeks, Pete Lollar

Blood (2014) 124 (21): 238.

https://doi.org/10.1182/blood.V124.21.238.238

Published: 2014

Journal Articles

Sensory Neuropeptides Prime the Splenic Marginal Zone for Optimal Humoral Immunity

Hubert Tsui, MD PhD, Magar Ghazarian, BSc, Shawn Winer, MD MSC, PhD, Hibret Adissu, DVM, DVSc, PhD, Michael Dosch, MD PhD, Marciano D. Reis, MD FRCPC, Daniel Winer, MD, Armand Keating, MD

Blood (2014) 124 (21): 4123.

https://doi.org/10.1182/blood.V124.21.4123.4123

Published: 2014

Journal Articles

Humoral Immunity and Plasma Cell Changes in Patients Responding to CD19-Specific Chimeric Antigen Receptor (CAR)-Modified T-Cell Adoptive Immunotherapy

Vijay Bhoj, MD PhD, Michael C Milone, MD PhD, Carl H. June, MD, David Porter, MD, Stephan A. Grupp, MD PhD, Jan J Melenhorst, PhD, Simon F. Lacey, PhD BSc, Colleen Callahan, MSN, CRNP, James Capobianchi, Gerald Wertheim, MDPhD, Yolanda Mahnke, PhD

Blood (2014) 124 (21): 1110.

https://doi.org/10.1182/blood.V124.21.1110.1110

Published: 2014

Journal Articles

Human mesenchymal stromal cells deliver systemic oncolytic measles virus to treat acute lymphoblastic leukemia in the presence of humoral immunity

Anna Castleton, Aditi Dey, Brendan Beaton, Bella Patel, Anne Aucher, Daniel M. Davis, Adele K. Fielding

Blood (2014) 123 (9): 1327–1335.

https://doi.org/10.1182/blood-2013-09-528851

Published: 2014

Includes: Multimedia, Supplemental data

Journal Articles

In Patients With Chronic Lymphocytic Leukemia (CLL) Ibrutinib Effectively Reduces Clonal IgM Paraproteins and Serum Free Light Chains While Increasing Normal IgM, IgA Serum Levels, Suggesting a Nascent Recovery Of Humoral Immunity

Georg Aue, MD, Mohammed Farooqui, DO, Jade Jones, Janet Valdez, PA, Sabrina E. Martyr, MD, Susan Soto, RN, Maryalice Stetler-Stevenson, MD, PhD, Constance Yuan, MD, PhD, Adrian Wiestner, MD, PhD

Blood (2013) 122 (21): 4182.

https://doi.org/10.1182/blood.V122.21.4182.4182

Published: 2013

Journal Articles

Humoral Immunity Induced By Viral Infection Provides a Major Barrier To Hematopoietic Cell Transplantation

Ravi Ruhil, Daniel Huang, Ozlem P Bulut, Stuart J Knechtle, Leslie S. Kean, Neal N Iwakoshi

Blood (2013) 122 (21): 894.

https://doi.org/10.1182/blood.V122.21.894.894

Published: 2013

Journal Articles

The Bcl6 RD2 Domain Is Essential For Pre-Germinal Center B Cell Development

Chuanxin Huang, PhD, Ann Haberman, PhD, Ari M. Melnick, MD

Blood (2013) 122 (21): 783.

https://doi.org/10.1182/blood.V122.21.783.783

Published: 2013

Journal Articles

Induction Of Anti-Myeloma Cellular and Humoral Immunity By Pre-Targeting Clonogenic Myeloma Cells Prior To Stem Cell Transplant With T Cells Armed With Anti-CD3 x Anti-CD20 Bispecific Antibody Leads To Transfer Of Cellular and Humoral Anti-Myeloma Immunity

Lawrence G Lum, MD, DSc, Archana Thakur, PhD, Zaid Al-Kadhimi, MD, Abhinav Deol, MBBS, MD, Lois Ayash, MD, Elyse N. Tomaszewski, BA, Hiroshi Yano, BS, Dana L Schalk, BS, MBA, Sri Vidya Kondadasula, MS, Patricia A. Steele, RN, BSN, Jeffrey A. Zonder, MD, Joseph P. Uberti, MD, PhD, Voravit Ratanatharathorn, MD, Muneer H. Abidi, MD

Blood (2013) 122 (21): 139.

https://doi.org/10.1182/blood.V122.21.139.139

Published: 2013

Journal Articles

Mef2C Maintains B Cell Homeostasis Through the Regulation of DNA Repair Machinery

Wenyuan Wang, Amelie Montel-Hagen, PhD, Rajkumar Sasidharan, PhD, Hanna K. A. Mikkola, MD, PhD

Blood (2012) 120 (21): 278.

https://doi.org/10.1182/blood.V120.21.278.278

Published: 2012

Journal Articles

Three-Dimensional Reorganization of the Genome During B Cell Affinity Maturation

Karen L. Bunting, PhD, David Soong, PhD, Yanwen Jiang, PhD, Brandon L. Swed, Katerina Hatzi, PhD, Rita Shaknovich, MD/PhD, William Reisacher, MD, Olivier Elemento, PhD, Ari Melnick, MD

Blood (2012) 120 (21): 279.

https://doi.org/10.1182/blood.V120.21.279.279

Published: 2012

Journal Articles

Patients with Diamond Blackfan Anaemia Have Abnormalities of Cellular and Humoral Immunity

Deena Iskander, MRCP, Yvonne Harrington, RCN, Irene Roberts, Anastasios Karadimitris, MD, PhD, Josu de la Fuente, PhD, FRCP, MRCPCH, FRCPath

Blood (2012) 120 (21): 3484.

https://doi.org/10.1182/blood.V120.21.3484.3484

Published: 2012

Journal Articles

The Early Rejection of Allogeneic BMC by Macrophages or NK Cells Is TRIF Signaling Dependent

Hong Xu, MD, Jun Yan, MD, PhD, Yiming Huang, MD, Suzanne T Ildstad

Blood (2012) 120 (21): 1883.

https://doi.org/10.1182/blood.V120.21.1883.1883

Published: 2012

NARROW

Computational Analysis Model Applied to Spanish Gaucher Registry Data

Myeloma Cells Have the Ability to Suppress Th1-Inducing Capacity but Enhance Th2-Mediated Response of Dendritic Cells By Producing Factors Other Than Soluble SLAMF7

Immune Dysfunction in Patients with MDS Is Partially Corrected in EPO-Treated Patients: Differences According to WHO Classification

A Phase 2 Study of Lenalidomide to Repair Immune Synapse Response and Humoral Immunity in Early-Stage, Asymptomatic Chronic Llmphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) with High-Risk Genomic Features

Sun C, Tian X, Lee YS, et al. Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib. Blood. 2015;126(19): 2213-2219 .

To B or not to B maintained?

Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy

The Role of Signal-Transducing Adaptor Protein-2 in Early T Lymphopoiesis in Thymus

Decreasing the Humoral Response to Factor VIII By Targeted Deletion of Factor VIII - Specific B Cells

Sensory Neuropeptides Prime the Splenic Marginal Zone for Optimal Humoral Immunity

Humoral Immunity and Plasma Cell Changes in Patients Responding to CD19-Specific Chimeric Antigen Receptor (CAR)-Modified T-Cell Adoptive Immunotherapy

Human mesenchymal stromal cells deliver systemic oncolytic measles virus to treat acute lymphoblastic leukemia in the presence of humoral immunity

In Patients With Chronic Lymphocytic Leukemia (CLL) Ibrutinib Effectively Reduces Clonal IgM Paraproteins and Serum Free Light Chains While Increasing Normal IgM, IgA Serum Levels, Suggesting a Nascent Recovery Of Humoral Immunity

Humoral Immunity Induced By Viral Infection Provides a Major Barrier To Hematopoietic Cell Transplantation

The Bcl6 RD2 Domain Is Essential For Pre-Germinal Center B Cell Development

Induction Of Anti-Myeloma Cellular and Humoral Immunity By Pre-Targeting Clonogenic Myeloma Cells Prior To Stem Cell Transplant With T Cells Armed With Anti-CD3 x Anti-CD20 Bispecific Antibody Leads To Transfer Of Cellular and Humoral Anti-Myeloma Immunity

Mef2C Maintains B Cell Homeostasis Through the Regulation of DNA Repair Machinery

Three-Dimensional Reorganization of the Genome During B Cell Affinity Maturation

Patients with Diamond Blackfan Anaemia Have Abnormalities of Cellular and Humoral Immunity

The Early Rejection of Allogeneic BMC by Macrophages or NK Cells Is TRIF Signaling Dependent

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only